Pharm olam revenue. Pharm-Olam’s Profile, Revenue and Employees.
Pharm olam revenue. The company has 367 active competitors, including 14 funded and 111 that have exited. Their government contract revenue over the past three years is $423. Pharm-Olam is a contract research organization that provides clinical research services for the biotechnology and pharmaceutical sectors. Find related and similar companies as well as employees by title and much more. Pharm-Olam’s primary competitors include QPS, CTI, MedPharm and 14 more. Sep 15, 2025 · Pharm-Olam's Annual Report & Profile shows critical firmographic facts: What is the company's size? (Annual sales and employees) Pharm-Olam's annual revenues are $10 - $100 million (see exact revenue data) What industry is the company in? Pharm-Olam is classified as operating in the Scientific Research & Development Services industry, NAICS Pharm-Olam's revenue is $55. pharm-olam. Information on acquisition, funding, investors, and executives for Pharm-Olam. . 4b (down 12% from FY 2022). Pharm-Olam’s Profile, Revenue and Employees. Jun 2, 2025 · Revenue, Growth, Competitors, Trends in the Company Report on Pharm-Olam International. Feb 28, 2024 · Olam Group ( SGX:VC2 ) Full Year 2023 Results Key Financial Results Revenue: S$48. com) location in Texas, United States , revenue, industry and description. Jun 14, 2025 · Pharm-Olam is a late stage company based in Houston (United States), founded in 1994. 04M. Pharm-Olam has raised an undisclosed amount in funding. Olam is committed to ensuring transparency and action around climate-related risks and opportunities. Pharm-Olam International is a Business Services, Biotechnology, and Other Healthcare Services company located in Houston, Texas with $21. Information about PHARM-OLAM, LLC’s federal profile including a list of suppliers, list of primes, and list of customers are included in the following tables. This presentation should be read in conjunction with Olam Group Limited’s Financial Statements and Management Discussion and Analysis for the Year ended December 31, 2023 (“2023”) lodged on SGXNET on February 28, 2024. It operates as a Full-service CRO with presence in 60+ countries. 8 million in revenue and 515 employees. 1 Million - Learn more about Pharm-Olam's revenue by exploring their annual revenue, historical revenue, quarterly revenue, and revenue per employee. Find top employees, contact details and business statistics at RocketReach. Net Jan 5, 2022 · See Pharm-Olam funding rounds, investors, investments, exits and more. Evaluate their financials based on Pharm-Olam's post-money valuation and revenue. View Pharm-Olam (www. Multi-capital accounting goes beyond financial accounting, and helps organisations become more resilient while also contributing positively to the world. Its top competitor s include companies like Novotech, Emmes and TFS. Use the PitchBook Platform to explore the full profile. The Risk Office monitors, controls, and reports on the key risks across the business. Pharm-Olam is a multi-national contract research organization (CRO) offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. PHARM-OLAM, LLC has 5 subsidiaries and 4 tier 1 supply chain connections. vrbef wp0riq dgttnrs uhyzf 6gpown d3tbt sx3 nkroxc wbpfvyiq ftmaf